JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRKL
1926
DELISTED
Brookline Bancorp
BRKL
| $11.6M | ﹤0.01% |
704,206
+163,610
| +30% | +$2.58M |
|
1927
Gen Digital
GEN
$17.7B
| $11.6M | ﹤0.01% |
453,044
-162,942
| -26% | -$3.98M |
|
|
GRFS
1928
Grifois
GRFS
$5.4B
| $11.6M | ﹤0.01% |
496,025
-1,641,789
| -77% | -$35.8M |
|
1929
Barnes & Noble Education
BNED
$424M
| $11.5M | ﹤0.01% |
27,017
-13,118
| -33% | -$5.39M |
|
1930
PUT
Sysco
SYY
$40B
| $11.5M | ﹤0.01% |
134,800
| – | – |
|
|
MAG
1931
DELISTED
MAG Silver
MAG
| $11.5M | ﹤0.01% |
973,298
-23,813
| -2% | -$246K |
|
1932
Vanguard Morningstar Large-Cap ETF
VV
$54.9B
| $11.5M | ﹤0.01% |
77,677
+2,415
| +3% | +$342K |
|
|
JRO
1933
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $11.5M | ﹤0.01% |
1,147,788
| – | – |
|
1934
WisdomTree Japan Hedged Equity Fund
DXJ
$7.55B
| $11.4M | ﹤0.01% |
212,763
+43,343
| +26% | +$2.31M |
|
1935
Acadia Realty Trust
AKR
$2.86B
| $11.4M | ﹤0.01% |
440,874
-85,418
| -16% | -$2.34M |
|
1936
PUT
Southwest Airlines
LUV
$22B
| $11.4M | ﹤0.01% |
210,800
| – | – |
|
1937
Personalis
PSNL
$1.54B
| $11.3M | ﹤0.01% |
1,040,042
+21,662
| +2% | +$225K |
|
1938
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.44B
| $11.3M | ﹤0.01% |
352,125
-125,742
| -26% | -$3.73M |
|
1939
Mueller Industries
MLI
$14.7B
| $11.3M | ﹤0.01% |
1,427,140
+732,036
| +105% | +$5.6M |
|
1940
Seacoast Banking Corp of Florida
SBCF
$3.48B
| $11.3M | ﹤0.01% |
370,361
+124,121
| +50% | +$3.53M |
|
|
RETA
1941
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $11.3M | ﹤0.01% |
55,340
-2,608
| -5% | -$476K |
|
1942
ScottsMiracle-Gro
SMG
$3.59B
| $11.3M | ﹤0.01% |
106,076
-44,761
| -30% | -$4.58M |
|
1943
SLM Corp
SLM
$5.22B
| $11.3M | ﹤0.01% |
1,263,709
-567,381
| -31% | -$4.93M |
|
|
SNR
1944
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $11.2M | ﹤0.01% |
1,469,532
-507,843
| -26% | -$3.77M |
|
1945
Financial Institutions
FISI
$825M
| $11.2M | ﹤0.01% |
349,810
-24,836
| -7% | -$783K |
|
1946
SolarEdge
SEDG
$1.98B
| $11.2M | ﹤0.01% |
117,921
-180,366
| -60% | -$15.4M |
|
1947
Genesco
GCO
$394M
| $11.2M | ﹤0.01% |
233,647
+20,571
| +10% | +$853K |
|
1948
AMERISAFE
AMSF
$504M
| $11.2M | ﹤0.01% |
169,560
-8,126
| -5% | -$538K |
|
1949
Maximus
MMS
$2.94B
| $11.2M | ﹤0.01% |
150,440
-47,119
| -24% | -$3.54M |
|
1950
CALL
Travelers Companies
TRV
$77.2B
| $11.2M | ﹤0.01% |
81,700
-3,500
| -4% | -$476K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.